Multi-centre randomised controlled trial of the cost-effectiveness of infra-inguinal percutaneous transluminal angioplasty (PTA) versus reconstructive surgery for severe limb ischaemia

Conditions

Cardiovascular diseases: Peripheral arterial disease Circulatory System Peripheral arterial disease

Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, Raab G, Ruckley CV.

2010-03-01109 citations

Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.

Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H, BASIL trial participants.

2005-12-011,257 citations

10.1016/s0140-6736(05)67704-5

Interventions

Please note that, as of 15 January 2008, the end date of this trial has been updated from 31 January 2004 to 31 December 2007. Interventions: 1. Percutaneous transluminal angioplasty (PTA) 2. Standa

Eligibility

Inclusion criteria

Inclusion criteria: Not provided at time of registration.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
1. A reduction on all-cause mortality and requirement for major limb amputation (primary clinical end-points) 2. Abolition of symptoms, procedure complications, secondary and cross-over interventions, minor amputation, quality of life measures and cost-effective utilisation of NHS resources (secondary end-points)	—

Secondary

Measure	Time frame
Not provided at time of registration.	—

Countries

United Kingdom

Outcome results

None listed